Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Euro Q3 Consumer Health Earnings Preview: Helm Changes, Investor Questions, Results Debut

Oct 17 2022

• By Tom Gallen

• Source: Alamy

Related Content

Europe’s Big Pharma Sails On Serenely Despite Choppy Economic Waters

Sep 05 2022

Haleon Starts Standalone Life By Raising Sales Expectations

Jul 29 2022

Sanofi Feeling Positive On Cialis Switch Progression As Q2 Sales Rise

Jul 29 2022

Reckitt Capitalizes As COVID Moves From Pandemic To Endemic

Jul 28 2022

US Q3 Consumer Health Earnings Preview: Coming Changes Overshadow Current Conditions?

Oct 17 2022

Euro Q4 Earnings Preview: GSK, Sanofi, Bayer And Reckitt

Jan 24 2022

Ranitidine Litigation Opens With Settlements, But Still Massive With State And MDL Trials Pending

Aug 19 2022

Bayer Places Consumer Cost Of Living Pressures 'Very High' On Agenda

Aug 08 2022

Reckitt's CEO Unexpectedly Quits After Three Years At The Helm

Sep 02 2022

Delay For Sanofi’s OTC Cialis Study In US Could Be Sign of Hurdles Holding Back Other Switches

May 31 2022

Sanofi Catching Up To Market Growth Rates As Q3 Sales Rise Double Digits

Oct 29 2021

GSK Raises Product Prices in US And Europe As Costs Rise

Oct 28 2021

Reckitt Raises Guidance Following Sharp Improvement In Cold & Flu Sales

Oct 27 2021

Successful Innovation And Supplement Gains Drive 'Exceptional' Q3 For Bayer

Nov 09 2021

Related Companies

Reckitt Benckiser Group PLC

Bayer AG

Sanofi

Haleon plc

GSK plc

Additional Topics

Europe Sales & Earnings Business Strategies Dietary Supplements OTC Drugs Consumer

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window